A laboratory in Maine is announcing a multimillion-dollar collaboration with pharmaceutical giant Sanofi to try to tackle two kinds of cancer.

Jackson Laboratory in Bar Harbor said Thursday it has signed a research agreement for up to $4.2 million with Sanofi to identify new targets to treat triple-negative breast cancer and ovarian carcinoma. The lab describes triple-negative as the most deadly form of breast cancer, and ovarian cancer as ranking fifth in cancer deaths among women. Read more